NVCT: Nuvectis Pharma Inc

NVCT新闻

• 13:55 Wall Street Analysts See a 61.46% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This High?
• 15:00 PepsiCo, Delta Air Lines To Report Earnings; FOMC's Minutes Of The Meeting In Focus
• 17:15 Nuvectis: 'Hold' On NXP800 Removal And Newly Licensed Candidates (NASDAQ:NVCT)
• 16:00 What Makes Nuvectis Pharma, Inc. (NVCT) a Strong Momentum Stock: Buy Now?
• 21:20 Biotech Is The Rate Cut Trade In Disguise
• 16:00 What Makes Nuvectis Pharma (NVCT) a New Buy Stock
• 06:30 Nuvectis Pharma Jumps 20% To 52-Week High — Here's Why NVCT Stock Is Trending - Nuvectis Pharma (NASDAQ:N
• 15:12 Nuvectis Pharma, Inc. (NVCT) Discusses Strategic In-Licensing Deal and Expansion Into Complement-Mediated Diseases and Oncology Prepared Remarks Transcript
• 13:55 Wall Street Analysts Think Nuvectis Pharma (NVCT) Could Surge 57%: Read This Before Placing a Bet
• 13:55 Wall Street Analysts Believe Nuvectis Pharma (NVCT) Could Rally 62.5%: Here's is How to Trade
• 12:05 Nuvectis initiates phase 1b trial combining NXP900 with osimertinib
• 12:37 H.C. Wainwright重申Nuvectis Pharma股票评级为"买入"
• 12:35 Nuvectis Pharma stock rating reiterated at Buy by H.C. Wainwright
• 13:09 卡普兰以64,240美元购入Nuvectis Pharma (NVCT)股票
• 13:09 Nuvectis Pharma董事长Bentsur购入价值28,600美元的股份
• 13:06 Nuvectis Pharma董事Sanchez以7.5万美元购入NVCT股票